Usually, a "case series" consists of a group of patients with nearly identical problems. The purpose of the report is to demonstrate a particularly advantageous diagnostic test or therapy. This report consists of five children with disparate ovarian tumors, each of which is unusual and interesting. (see [Tables 1](#tbl1){ref-type="table"}, [2](#tbl2){ref-type="table"}).Table 1Case series.Table 1CaseClinical\
SettingTumor\
HistologyAnatomic\
LocationDiagnostic ChallengeTherapeutic DifficultyInteresting Features1PubertyGrade III\
Stage III\
**Immature**\
**Teratoma**Right Ovary with *Gliosis Peritonei* Tumor Implants Carpeted the PelvisMultiply Recurrent\
Despite Evidence of Maturation\
Why?Neovascularity,\
Utility of Chemotherapy in Treating Pediatric\
**IT**Unrecognized\
Metachronous,\
Contralateral\
**MT**2PubertyStage II **JGCT**Right Ovary -Capsular Tear -- Tumor SpillageOllier\'s Syndrome\
Versus Bone\
MetastasisOmental Neovascularity,\
An Indication for Chemotherapy?Tumor\'s Behavior\
Belied its Gross\
Appearance3InfancyStage II **MT/YST**Fundus of StomachAnemia from Gastric Hemorrhage/PerforationTumor Recurrence: **YST**, **IT**, or **MT**?\
Chemotherapy for Islands of **YST?**Abdominal Teratoma\'s Unpredictable\
Anatomy4InfancyGrade I\
Stage I, **IT**Small Bowel\
MesenteryMesenteric Cyst Versus TeratomaGrade I **IT**Difficulty in Anticipating\
Surgical Pitfalls5InfancyStage IV **Chorio-carcinoma**Skin/LungsMistaken as Abscess, then as Vascular MalformationDiagnostic Ambiguity Leads to Therapeutic\
InaccuracyA Biopsy to Ascertain Tissue Diagnosis Is Crucial.[^1][^2]Table 2Definition of terms \[[@bib1],[@bib2]\].Table 2Stage 1: Unilateral Tumor Completely ResectedGrade 1: \<1 Foci of Immature Teratoma/Low Power Field (Microscopic)Stage 2: Incomplete Resection with Microscopic ResidualGrade 2: 1--3 Foci of Immature Teratoma/Low Power Field (Microscopic)Stage 3: Gross Residual Tumor with Spread to Contiguous Organs (LN\'s, Omentum, Ascites)Grade 3: \>3 Foci of Immature Teratoma/Low Power Field (Microscopic)Stage 4: Distant Tumor Spread/Liver, etc.

What makes for an interesting case?∗It occurs infrequently.∗It is intellectually or technically challenging.∗It is puzzling; the denouement is not immediately apparent; it is rather surprising, even counter-intuitive.

Interesting cases are educational; they pique our curiosity; and they are memorable!

The first two cases in this series are adolescent girls with huge ovarian tumors. The resections were immensely challenging, which is unusual in itself! Salpingo-oophorectomy usually proceeds uneventfully; these tumors had parasitized the omentum, and their mobilization required division of fragile blood vessels so numerous as to resemble hydras! Both tumors appeared malignant, but the clinical outcome belied the surgeon\'s prognostication.

The third case is an infant who presented with a hugely distended abdomen and GI bleeding (his hemoglobin and hematocrit were 2.7 gm% and 12.2%); the etiology was a teratoma that had eroded into his stomach.

The fourth case is a newborn with an abdominal mass, diagnosed (by MR) as a mesenteric cyst. Actually, it was an Immature Teratoma arising from the small bowel mesentery.

The last case is a newborn who presented with a raised, erythematous swelling in her right cheek. Was it an abscess, a vascular malformation, or a tumor?

1. Ovarian tumors are complex and confusing! {#sec1}
============================================

They are rare; the incidence of ovarian masses is only 5/100,000 girls/year; half are neoplastic; half are cystic. Only 1% of childhood cancers are ovarian; and only 1% of ovarian malignancies occur during childhood. Ovarian tumors are less frequent in young children, but the incidence of malignancy is greater. Epithelial tumors are more common in older women, and the prognosis in adults is worse, because they present with more advanced disease, and adenocarcinoma is less responsive to chemotherapy ([Tables 3](#tbl3){ref-type="table"}, [4](#tbl4){ref-type="table"}) \[[@bib1]\].Table 3Overview of ovarian tumors in children.Table 3FrequencyTumor DerivationClassificationMarkerRadiographic Appearance75%**Germ Cell**\
Undifferentiated:\
Differentiated:\
1. Embryonic\
2. Extra-embryonicDysgerminoma\
Mature Teratoma\
Immature Teratoma\
Embryonal Cell\
Yolk Sac\
ChoriocarcinomaLDH\
AFP bHCG\
AFP\
bHCGSolid with Fibro-vascular Septae\
MT: Cystic, Fat, Ca++\
IT: Heterogeneous\
Solid\
Heterogeneous\
Vascular45%**Pure:**\
One Germ Cell Type25% YST\
18% Dysgerminoma\
2% Choriocarcinoma55%**Mixed**\
Multiple Germ Cell Types30% Teratoma + YST\
10% Teratoma + Others[a](#tbl3fna){ref-type="table-fn"}\
13% Multiple Non-Teratoma[a](#tbl3fna){ref-type="table-fn"}\
2% Gonadoblastoma + Others[a](#tbl3fna){ref-type="table-fn"}10%**Sex Cord Stroma**Granulosa-Theca\
Sertoli-LeydigInhibinMulti-cystic,\
Irregular Septa15%**Epithelial**Serous or Mucinous,\
AdenocarcinomaCA 125[^3]Table 4When is an ovarian mass malignant or benign \[[@bib3]\]?.Table 4Likely MalignantCystic versus Solid?Size: \< or \>9 cmMarkers: AFP/BHCGHighSolid\>9 cm+IntermediateCystic or Heterogeneous\>9 cm--LowCystic\<9 cm--[^4][^5]

Characteristics of Teratomas ([Tables 5](#tbl5){ref-type="table"}, [6](#tbl6){ref-type="table"}) \[[@bib4], [@bib5], [@bib6], [@bib7], [@bib8]\]:•They are heterogeneous and contain areas of fat density and calcification.•They are lobulated, smooth, and encapsulated.•All 3 embryonic layers (endoderm, mesoderm, and ectoderm) are represented.•The incidence of teratomas peaks in late adolescence. Most are mature; immature teratomas comprise only 1% of ovarian tumors.•20% Teratomas are bilateral, either metachronous or synchronous.•10% are immature (neuroepithelial cells) or have a malignant component, YST.•The terms *mature/immature* are analogous, but without the same connotation, as *differentiated/undifferentiated, benign/malignant.*•*Gliosis peritonei*, associated with mature teratomas, denotes intraperitoneal spread of tumor, yet it is benign.Table 5Age adjusted incidence of teratomas.Table 5Age in YearsOccurrence0--510%5--1020%10--1570%Table 6Anatomic distribution of childhood teratomas.Table 6FrequencySite45%Sacrococcygeal27%Ovary5%Testes6%Mediastinal4%Retroperitoneal5%CNS6%Cervico-facial1%Pericardial1%Gastric, Hepatic, Umbilical

Embryogenesis of Teratomas:•Post meiotic germ cells migrate from the yolk sac and allantois along the dorsal mesentery to the genital ridge, guided by cKit receptors and stem cell factors.•Half of germ cell tumors (GCT) are ovarian; the other half is dispersed widely, because of aberrant or arrested migration.

The incidence of Juvenile Granulosa Cell Tumors peaks during childhood. These tumors grow rapidly, becoming quite large, but behave with moderate to low grade virulence. Complete resection yields an overall survival of 95% in children who are less than 10 years old, even if the tumor ruptures.

JGCT derive from uncommitted mesenchymal stem cells located beneath the urogenital ridge. Sex cord stroma cells are hormonally active, secreting estrogen or testosterone and suppressing the release of gonadotropins. Children present with increased girth, precocious puberty, menstrual irregularities, galactorrhea, or virilization. Inhibin B and antimullerian hormone values are proportional to follicular growth. Paraneoplastic release of parathyroid hormone may cause elevation of serum calcium. Cytogenetic aberrations, such as chromosome deletions and tumor suppressor gene mutations, have been identified in these tumors. Cisplatin, Etoposide, and Bleomycin are utilized in patients with advanced disease: tumor that is unresectable or recurrent, with high mitotic activity or nuclear atypia, or with ascites \[[@bib9], [@bib10], [@bib11], [@bib12]\].

Syndromic Sex Cord Stroma Tumors usually occur during the first decade of life, and these tumors are benign, as in Case \#2.

Ollier\'s Syndrome (Enchondromatosis) is a non-hereditary syndrome of mesodermal dysplasia. Fragments of the epiphyseal plate are incorporated into growing bone, forming enchondromas. The deranged cartilage may undergo a malignant transformation to chondrosarcoma ([Table 7](#tbl7){ref-type="table"}).Table 7Syndromes associated with sex cord stroma tumors.Table 7SyndromeClinical CharacteristicsAssociated TumorsPeutz JegherPerioral Melanin Pigmentation, Intestinal PolypsJGCTG, AnnularTubules,CystadenomaMaffucciSubcutaneous HemangiomasJGCT, FibrosarcomaOllier\'sEnchondromas, Unilateral Leg Length DisparityJGCT, Sertoli Leydig Cell Tumors

2. Materials and methods {#sec2}
========================

This report was prepared in accord with the PROCESS criteria \[[@bib13]\]; it consists of five case histories from the principal author\'s pediatric surgical practice; three children were treated at USA Children\'s and Women\'s Hospital, Mobile, AL; and two were treated at Palmetto Health Children\'s Hospital, Columbia, SC.Case 1Stage 3, Grade 3 Immature Teratoma

[Case 1](#enun_1){ref-type="statement"} is a 12 years old, pubertal young lady who presented with abdominal distension, so massive that her parents thought she was pregnant ([Fig. 1](#fig1){ref-type="fig"})! A CT scan disclosed an ovarian tumor that had areas of calcification and fat, which is consistent with a teratoma. The demarcation between the MT and IT is apparent in the operative specimen and on the CT scan. It is as if the immature component burst forth with explosive tumor growth from the confines of the well encapsulated ([Fig. 2](#fig2){ref-type="fig"}). MT. Surgery revealed widespread *gliomatosis peritonei* with carpeting of the pelvic peritoneum, including the serosal surface of the sigmoid colon. Pathology reported 20% Immature Teratoma ([Figs. 4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"})Fig. 1Operative specimen.Fig. 1Fig. 2CT scan of Original Tumor.Fig. 2Fig. 3Serial MR\'s of "recurrent" tumor.Fig. 3Fig. 4High grade immature teratoma with multifocal primitive neuroepithelium (H&E Zeiss 200x).Fig. 4Fig. 5Mature teratomatous elements (including skin, hair follicles, bone, and cartilage) with focal YST (H&E Zeiss 200x) inset: Staining positive for alpha fetoprotein (AFP Zeiss 400x).Fig. 5

2.1. Treatment milestones {#sec2.1}
-------------------------

Even though there was gross residual tumor, the oncologists advised a "wait and see" approach \[[@bib14]\]. And predictably, the tumor recurred. Since Teratomas may be mixed ([Table 3](#tbl3){ref-type="table"}), careful evaluation of the re-operative specimen for possible malignant elements was advised. None were identified; however, the proportion of Immature Teratoma had diminished to 15%.

An MR was obtained four months later; and again, tumor was present. Surprisingly though, the operative procedure was technically easier. The tumor appeared contained, less aggressive; and pathology review corroborated this impression ([Fig. 3](#fig3){ref-type="fig"}). Only 5% of the tissue was IT. The left ovary was distorted and cystic but uninvolved by tumor. The clinicians were optimistic, then baffled by the imaging studies that appeared to show "recurrent" tumor. The oncologists began chemotherapy (Bleomycin, Etoposide, and Cisplatin) hoping to hasten maturation of the teratoma. Repeat imaging was also disappointing; the tumor appeared to be enlarging, rather than diminishing in size. Why? Had chemotherapy created a "growing teratoma?" The only hope seemed to be radical extirpation of this stubborn tumor, but the operative specimen revealed a metachronous, contralateral Mature Teratoma ([Tables 8](#tbl8){ref-type="table"}, [9](#tbl9){ref-type="table"}) \[[@bib8]\]!Table 8Summary of imaging studies.Table 8DateSize of MassDescriptionMR Interpretation01/04/20179.4 × 8.1 × 6.5 cmComplex Multi-cystic Mass in Rectovaginal SpaceRecurrent IT01/30/20175.3 × 5.2 × 5.1 cmComplex Multi-cystic Mass of Left AdnexaRecurrent IT04/14/20176.9 × 5.9 × 5.4 cmGrowth of Cystic, Fatty Components of Left AdnexaRecurrent ITTable 9Chronology of tumor histology.Table 9\
DateAFPSize of TumorPathology04/201682.924 × 30 × 18Mature Teratoma Right Ovary Containing Brain, Choroid Plexus, Kidney, Respiratory Epithelium, Adipose, Skin with Hair, Hyaline Cartilage\
16% Immature Teratoma (High Grade Neuroepithelium) in tumor\
100% Immature Teratoma in Gliomatosis Peritonei\
20% Immature Teratoma in Pelvic Implants + Ascitic Fluid with Abundant Atypical Cells08/201657.59 × 9 × 9.6Recurrent Teratoma (15% High Grade Neuroepithelium)01/2017219.4 × 8 × 6.5Recurrent Teratoma (5% High Grade Neuroepithelium)03/20178.206/20173.37 × 6 × 5.4Ovarian Follicles (Contralateral) and Mature Teratoma + Gliomatosis Peritonei, 0% IT

3. Discussion of case 1 {#sec3}
=======================

Principles Guiding the Treatment of Immature Teratoma \[[@bib2],[@bib14]\]:1.Grade of tumor is the most significant prognostic variable; tumor Stage is next (see Addendum)2.Adults with high grade Immature Teratoma receive chemotherapy but may still relapse.3.Children with completely excised Immature Teratomas are not treated with chemotherapy, even in tumors containing foci of Yolk Sac Tumor.4.Chemotherapy has no proven benefit in treating children with Grade III, Stage III Immature Teratoma; there evidence that it hastens the maturation of IT.5.Chemotherapy is utilized only in desperate cases, where extirpation is not feasible.6.The "growing teratoma syndrome" occurs when chemotherapy destroys the malignant cells (YST) while growth of immature neuroepithelial cells continues unabated.Case 2Juvenile Germ Cell Tumor Associated with Ollier\'s Disease

A 13 years old pubertal young lady presented with abdominal distension and discomfort, and isosexual precocious puberty. The tumor was huge (33 × 15.5 × 33 cm), and it was adherent to the surrounding structures ([Figs. 6](#fig6){ref-type="fig"}, [7](#fig7){ref-type="fig"}). As the dissection progressed inferiorly and laterally, the operative incision was stretched open to provide better exposure. Pulling the retroperitoneum tore the tumor capsule and caused torrential hemorrhage. Fortunately, most of the omental vessels had been ligated, and the bleeding was arrested expeditiously by controlling the ovarian pedicle.Fig. 6Operative specimen.Fig. 6Fig. 7Scans of juvenile germ cell tumor.Fig. 7

This young lady was followed post-operatively with tumor markers and imaging. Her tumor never recurred, which is consistent with the observation that syndromic patients, even those with tumor rupture, have an excellent prognosis.

3.1. Discussion of second case {#sec3.1}
------------------------------

What triggers tumor neovascularity, the ingrowth of omental blood vessels into certain tumors, notably ovarian tumors and uterine fibroids \[[@bib15]\]? Perhaps rapid growth of the tumor exceeds its blood supply; the resultant ischemia causes release of angiogenic mediators.

The omentum is termed "policeman of the abdomen"! In laparoscopy, we are taught to "follow the omentum" to the pathology! It is indeed a remarkable organ, derived from mesothelial cells, consisting of adiposites and lymphoid aggregates. Omental lymphatics filter antigens and pathogens from ascitic fluid, a process vital to developing immunity and protecting the peritoneal cavity. Chemotactic stimuli lead the omentum to foci of inflammation, where recruitment of inflammatory cells (lymphocytes and phagocytes) combat infection. Stem cells promote wound healing by angiogenesis and fibrosis. Metastatic cells are filtered so effectively that omental lymphatics may be clogged by tumor cells \[[@bib16]\].Case 3A Teratoma that Eroded into the Stomach ([Fig. 8](#fig8){ref-type="fig"})Fig. 8Operative specimen.Fig. 8

A 9 months old boy presented with abdominal distension, hematemesis, and profound anemia (HGB 2.7/HCT 12.2). He received 5 units of blood pre-operatively. He had a huge teratoma that was attached to the caudate lobe of the liver and the antrum of the stomach. The tumor had eroded through the stomach wall, causing hemorrhage and leakage of gastric contents into the tumor ([Figs. 8](#fig8){ref-type="fig"}, [9](#fig9){ref-type="fig"}) \[[@bib17], [@bib18], [@bib19]\].Fig. 9CT scan of Gastric Teratoma.Fig. 9

Pathology was Mature Teratoma with islands of Yolk Sac Tumor. The child was not treated with chemotherapy in accordance with principle \#3 above. The tumor did recur where it was originally attached ([Fig. 10](#fig10){ref-type="fig"}), but the histology was MT (not YST). These recurrences were excised and never recurred.Case 4Infant with Mesenteric TeratomaFig. 10CT scan Showing Recurrence in Stomach and Liver.Fig. 10

The radiographic (MR) diagnosis in this infant was "mesenteric cyst" ([Fig. 11](#fig11){ref-type="fig"}). The excision was uneventful, but the pathology finding was unexpected: Grade I Immature teratoma without malignant elements. There was never any recurrence.Fig. 11MR.Fig. 11

4. Discussion of cases 3 and 4 {#sec4}
==============================

Retroperitoneal teratomas are notorious for distorting or obliterating the vascular anatomy. The renal vessels may be splayed apart; and/or the vena cava and/or portal vein may be encased by tumor, making resection particularly difficult \[[@bib20],[@bib21]\]. Taking a cue from hepatoblastoma surgery, it was hoped that pre-operative chemotherapy would shrink the tumor and facilitate removal. Unfortunately the desired effect was not achieved. Chemotherapy effectively destroyed the malignant elements, but allowed unfettered growth of the immature teratoma, termed a "growing teratoma" (Principle \#5, above).

The location of our tumors was intra-abdominal rather than retroperitoneal. The anatomy was distorted by their large size, but the vasculature was displaced rather than obscured, and their resection was straight-forward.Case 5Metastatic Gestational Choriocarcinoma

This baby\'s mother brought her to the emergency department, because of the growth on her cheek.([Fig. 12](#fig12){ref-type="fig"}). Surgery was consulted for drainage of an "abscess". The photos were taken for consultation with an oncologist and otolaryngologist. An MR was obtained and the mass was thought to be a "vascular malformation". She was admitted and treated with propranolol and prednisone, and the lump transiently diminished in size; however, the mass ulcerated and bled, leading to readmission and transfusion; ultimately, she was referred to another institution for embolization. Unfortunately, she was lost to follow-up for a time; and when she reappeared, the tumor had grown to monstrous proportions ([Fig. 13](#fig13){ref-type="fig"}). Obviously, the initial diagnosis of vascular anomaly was erroneous. Biopsy revealed choriocarcinoma, and an elevated HCG and pulmonary metastasis. Her mother\'s HCG, also, was elevated, presumably from uterine involvement. Both mother and child responded well to chemotherapy and are disease free.Fig. 12Photos of infant.Fig. 12Fig. 13Mr of the choriocarcinoma.Fig. 13

5. Discussion {#sec5}
=============

This is a case of gestational choriocarcinoma arising in the mother\'s placenta, metastatic to the infant. Newborns with this disease usually present with anemia, hepatomegaly, and precocious puberty. Metastatic disease may involve the liver, lungs, brain, and skin \[[@bib22]\].

Gestational choriocarcinoma occurs in 1/50,000 pregnancies. Non-gestational choriocarcinoma is even rarer; it arises from malignant degeneration of extra-embryonic germ cells in the brain, mediastinum, or gonads.

6. Conclusion {#sec6}
=============

We learn from interesting cases, and [Case 1](#enun_1){ref-type="statement"} is illustrative of two errors that clinicians are especially prone to make:1.Allowing emotion (rather than reason) to dictate therapeutic decisions2.Jumping to conclusions (Cognitive Bias)

The oncologic data *is* ambiguous: adults with IT routinely receive chemotherapy, but children do not. Should an adolescent (a pubertal young lady) be treated as an adult or a child? Yet there is no evidence that IT responds to chemotherapy in either case. That conviction initially guided therapy; it was the best "evidence based treatment". But the young lady\'s clinical course confounded the expectations of her physicians, causing them to question their initial decision. Considering her multiple recurrences, should not chemotherapy be tried?

The quandary for clinicians is that sometimes reappraisal and change is necessary; in other instances, the correct posture is to *stay the course*!

Clinicians are like detectives. What makes Sherlock Holms the master sleuth? His perception is more acute, and his conclusions are more accurate. A less competent detective jumps to conclusions, which inevitably do not take into account all of the facts. Once a theory is embraced, clues that contradict it are overlooked.

Clinicians do the same thing, as is demonstrated in [Case 1](#enun_1){ref-type="statement"}. By (almost) all measures, the teratoma was becoming more mature (pathology, AFP levels, and gross appearance); however, this evidence was seemingly contradicted by the radiographs, which showed "persistent" or "recurrent" Immature Teratoma.

Choosing one explanation (assigning a label) obfuscates other possibilities.[1](#fn1){ref-type="fn"} Our sure convictions cause us to overlook crucial bits of information. The evidence of increasing benignity was ignored, and a therapeutic approach was tailored to rid the patient -- once and for all - of tumor. Teratomas may be metachronous and bilateral \[[@bib17]\]. Sherlock Holms would have considered this fact and chosen a more nuanced surgical approach.

Mark Twain, "*It\'s not what we don\'t know that gets us into trouble. It\'s what we know for sure that just ain\'t so."* Our certain conclusions may be "dead wrong" and cause us "double trouble". The error is compounded by delayed recognition.

[Case 5](#enun_5){ref-type="statement"} reinforces the lesson that interpretations of radiographs may be flawed. No one wants to biopsy a vascular malformation, but correct diagnosis precedes appropriate therapy.

Interesting cases are engaging and memorable, and they illustrate important lessons:•Once the best *evidence based therapy* is determined, "Stay the course!"•Don\'t jump to conclusions. Make sure your solution to diagnostic dilemmas take into account all the facts.•Don\'t take short cuts. Correct diagnosis always precedes effective therapy.
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Appendix A. Supplementary data {#appsec1}
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The following are the Supplementary data to this article:Process ChecklistProcess ChecklistAddendum_V2Addendum_V2

Einstein famously introduced a "fudge factor" into his gravitational equations to prevent the universe from imploding! The facts were made to conform to the theory rather than vice versa.

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.amsu.2018.11.011>.

[^1]: Glossary of Terms.

[^2]: **MT** -- mature teratoma, **IT** -- immature teratoma, **JGCT** -- juvenile granulosa cell tumor, **YST** -- yolk sac tumor.

[^3]: Dysgerminoma, Embryonal Cell or Choriocarcinoma.

[^4]: AFP \< 10 ng/mL is normal.

[^5]: AFP \>1000 ng/mL indicates malignancy and demands more aggressive management \[[@bib2]\].
